ArticleBiomedicines2022

Clinical Impact of Monoclonal Antibodies in the Treatment of High-Risk Patients with SARS-CoV-2 Breakthrough Infections: The ORCHESTRA Prospective Cohort Study.

Alessia Savoldi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.